Congenital Hemophilia A Ha clinical trials

Explore recruiting congenital hemophilia a ha clinical trials.

Also recruiting in Europe

Congenital Hemophilia A Ha trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efanesoctocog alfa treatment in patients with synovitis in congenital hemophilia A: multicenter, randomized, open-label, phase 3 clinical trial

Austria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Congenital Hemophilia A Ha trials by city

Congenital Hemophilia A Ha in Toronto Congenital Hemophilia A Ha in Vancouver Congenital Hemophilia A Ha in Montreal Congenital Hemophilia A Ha in Calgary Congenital Hemophilia A Ha in Edmonton Congenital Hemophilia A Ha in Ottawa Congenital Hemophilia A Ha in Winnipeg Congenital Hemophilia A Ha in Quebec City Congenital Hemophilia A Ha in Hamilton Congenital Hemophilia A Ha in Kitchener Congenital Hemophilia A Ha in London Congenital Hemophilia A Ha in Halifax Congenital Hemophilia A Ha in New York Congenital Hemophilia A Ha in Los Angeles Congenital Hemophilia A Ha in Chicago Congenital Hemophilia A Ha in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease